Anti-TNF-alpha therapy in ankylosing spondylitis

This publication has 20 references indexed in Scilit:

• Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
  New England Journal of Medicine, 2004
• Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study
  Annals of the Rheumatic Diseases, 2003
• Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
  New England Journal of Medicine, 2000
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
  The Lancet, 1999
• Review article: the efficacy of infliximab in Crohn’s disease — healing of fistulae
  Alimentary Pharmacology & Therapeutics, 1999
• BOWEL INFLAMMATION AND THE SPONDYLOARTHROPATHIES
  Rheumatic Disease Clinics of North America, 1998
• Long-term evolution of gut inflammation in patients with spondyloarthropathy
  Gastroenterology, 1996
• Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis
  Arthritis & Rheumatism, 1995
• SERUM CYTOKINES (IL-6, TNF-α, IL-1β AND IFN-γ) IN ANKYLOSING SPONDYLITIS: A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE ACTIVITY AND SEVERITY
  Rheumatology, 1994
• Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients
  Arthritis & Rheumatism, 1994